7/13*********NEW INVESTORS POST***********
********HELLO, ANYONE AWAKE?********
we really need to talk about this paragraph from yesterday's announcement. the bashing and the worry about nasdaq has obliterated our focus on the mission set out two years ago by coii--to finish clinical trials.
"I believe that we may now have sufficient patient data to complete the preparation of Module 5. It will take several more weeks to complete the data confirmation and audit process to ensure that the data for each trial patient is complete and accurate. Since the audit process may cause some attrition, we are continuing to collect data at all of our clinical sites in order to fill any shortfall that may arise. "
THEY HAVE DONE IT!!!!!!!!!!
DO YOU REALIZE WHAT THAT MEANS? DONE!!!!!!
JUST WRAP UP THE DATA AND SEND IT IN TO THE FDA AND WE WILL BE APPROVED QUICKLY!!!!!!!!!!
MY GUESS ABOUT THE PIPELINE:
module 3 should be approved very soon.
4 is being prepared right now--going in to fda in august would not surprise me.
module 5 should not be far behind it--my guess is september or october.
we should hear from nasdaq this week or next.
we should be approved by the FDA by november
these are just my guesses--i could be right or wrong, of course.
---------------------------------------------------------
COII (CTI) is the leader in the emerging field of thermal medical imaging.
They will be first to market with a computerized thermal imaging system to be used inititally as an adjunct to mammography. They have at least a one year head start on all competitors. Orders from foreign countries are already being taken(we assume)and they have plenty of
funding for a fast and furious national roll-out.
CTI will help stop the breast cancer epidemic. Then, they will become major players in the diagnosis of back/neck
pain(work injuries), followed by many other potential areas such as dermatology, cardioloigy, etc.
Their breast cancer detection system should be approved by summer/fall 2000.
Use these links to help you in your study of COII.
1. Go to the Silicon Investor "research" thread and read the last 5-15 posts, at least.
Subject 21613
2. Go to the company website and study it--especially the thermal images of cancer vs. normal tissue..see news release from Feb. for images:
cti-net.com
3. Go to the yahoo COII "profile"
biz.yahoo.com
4. Institutional buying interest has started.
insidertrader.com
5. CTI may eventually replace mammography as the screening of choice for breast cancer--then it could be back/neck
pain, melanoma, etc.
CTI's EARNING POTENTIAL
Let's assume that 1-2 years after approval:
300 imaging centers X 200,000-400,000 net/system = 60M net
note: this is conservative. it is possible they could make FAR more per system. think about it: they can process 4-6 ladies per hour. each breast will NET around $30, with most women having both done for total of $60 per exam.
$50 x 4/hour x 8 hr. day x 6 days/week x 50 weeks/yr. =
NET of 480,000 per year.
Then assume they sell sell 200 systems x 250,000 net = 50M NET ONE YEAR AFTER APPROVAL = $110M
ASSUME 110M SHARES OUTSTANDING GIVES US $1/SHARE
So if we assume that they have a p/e of 50 during the first couple years (this would drop to 25 after 1-2 years) it would give a stock price of:
$50 with a 50 p/e or $25 with a 25 p/e
My one year price projection after approval is $25-$50
My 2-3 year projection is $50-$100
My 5+ year prjection is $100-$200
These are all back of the envelope estimates and have no guidance from the company. I will update these estimates as time progresses. If anyone has any suggestions, please let me know. Please realize that all of these computations are very conservative.
CTI will have a great run for at least 2-3 years. The long term investor wins with CTI.
note: the above are only my estimates and could be right or wrong.
curtis |
